TGFB1 and hepatocellular carcinoma: Comparing the untreated HCC-bearing mice, our cellular and molecular studies showed that significant increase of T-cell tumor infiltration, enhancement of cytotoxic IFN-γ, and reduction of suppressive TGF-β which could be detected in tumor-bearing mice 30 days post inCVAX treatment.